Drug Search Results
More Filters [+]

Droperidol

Alternative Names: droperidol, dehydrobenzperidol, xomolix, inapsine, innovar
Latest Update: 2024-02-26
Latest Update Note: Clinical Trial Update

Product Description

Droperidol injection is used to prevent the nausea and vomiting that may occur after surgery or diagnostic procedures. (Sourced from: https://www.mayoclinic.org/drugs-supplements/droperidol-injection-route/side-effects/drg-20063582?p=1)

Mechanisms of Action: D2 Antagonist,ADRA1A Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Intramuscular

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Austria | Belgium | Brazil | Canada | Chile | China | Colombia | Croatia | Denmark | Dominican Republic | Finland | France | Germany | Greece | Hungary | Iceland | India | Ireland | Italy | Latvia | Luxembourg | Netherlands | New Zealand | Norway | Peru | Portugal | Romania | Russia | Saudi Arabia | Slovenia | South Africa | Spain | Sweden | Switzerland | Taiwan | United Kingdom | United States | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Droperidol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events